Skip to main content
Pharma Mar S.A. logo

Pharma Mar S.A. — Investor Relations & Filings

Ticker · PHM ISIN · ES0169501022 LEI · 959800QWKZ45ZQC2AV58 MC Manufacturing
Open in API
Filings indexed 351 across all filing types
Latest filing 2022-08-05 Regulatory Filings
Country ES Spain
Listing MC PHM

About Pharma Mar S.A.

https://pharmamar.com/en/

Pharma Mar S.A. is a biopharmaceutical company specializing in the discovery, development, and commercialization of oncology treatments derived from marine sources. A pioneer in its field since 1986, the company leverages marine biodiversity to develop innovative therapies for cancer, with a particular focus on rare tumors. Its integrated R&D pipeline spans from the exploration of marine invertebrates to the marketing of approved drugs. The company maintains an extensive collection of over 500,000 marine samples, which serves as the foundation for its drug discovery programs. Key commercialized products include Yondelis® (trabectedin) for advanced soft tissue sarcoma and ovarian cancer, Zepzelca® (lurbinectedin) for small cell lung cancer, and Aplidin® (plitidepsin) for multiple myeloma.

Recent filings

Filing Released Lang Actions
La Sociedad anuncia la designación de lurbinectedina como medicamento innovador por parte de la MHRA del Reino Unido.
Regulatory Filings Classification · 98% confidence The document is a formal communication addressed to the 'Comisión Nacional del Mercado de Valores' (CNMV, the Spanish securities market regulator) dated August 5, 2022. It announces 'OTRA INFORMACIÓN RELEVANTE' (Other Relevant Information) regarding Pharma Mar's drug, lurbinectedin, receiving the 'Innovation Passport' designation from the UK's MHRA. Crucially, the text states, 'Se adjunta nota de prensa que será distribuida a los medios de comunicación en el día de hoy' (A press release that will be distributed to the media today is attached). This structure—a brief regulatory filing announcing the release of a press release/news—fits the definition of a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Since the core content is the announcement of a specific regulatory/clinical milestone and the attachment of a press release, and it is not the full financial report (10-K, IR) or a transcript (CT), RPA is the most precise fit, as it signals the publication of external information. Given the context of regulatory disclosure in Spain, RNS is also a strong candidate, but RPA specifically captures the 'announcement of publication' aspect mentioned in the text.
2022-08-05 Spanish
La Sociedad publica la presentación a analistas e inversores anunciada para mañana, relativa a los resultados del primer semestre de 2022.
Investor Presentation Classification · 98% confidence The document is explicitly titled "1H 2022 Results Presentation" and contains detailed sections on "FINANCIAL HIGHLIGHTS," "OPERATIONAL UPDATE," and clinical pipeline data, dated July 28th, 2022. This structure strongly indicates a presentation summarizing performance for the first half of the fiscal year. This aligns best with an Investor Presentation (IP), which typically accompanies or precedes the formal Interim/Quarterly Report (IR) or Earnings Release (ER). Since it is a presentation format (slides with bullet points, figures, and speaker notes) rather than a formal narrative report, 'Investor Presentation' (IP) is the most accurate classification. It is not a short announcement of a report (RPA/RNS), as the document itself is substantial (over 10,000 characters) and contains the core results information.
2022-07-27 English
La Sociedad remite detalle de las operaciones del Contrato de Liquidez comprendidas entre el 01/04/2022 y el 30/06/2022
Transaction in Own Shares Classification · 98% confidence The document is addressed to the 'Comisión Nacional del Mercado de Valores' (CNMV), the Spanish securities market regulator. The title is 'OTRA INFORMACIÓN RELEVANTE' (Other Relevant Information) and the subject is 'Operaciones trimestrales contrato de liquidez' (Quarterly operations under a liquidity contract). It details the buying and selling of the company's own shares (treasury stock operations) for the second quarter of 2022 (April 1 to June 30, 2022). This type of filing, reporting transactions in a company's own shares, directly corresponds to the definition of 'Transaction in Own Shares' (POS). It is not a general regulatory filing (RNS) because it fits a specific category, nor is it an announcement of a report (RPA) as it contains the detailed data itself.
2022-07-07 Spanish
La Sociedad comunica cambios en la composición de su Consejo de Administración y de sus Comisiones.
Board/Management Information Classification · 98% confidence The document is a formal notification addressed to the Comisión Nacional del Mercado de Valores (CNMV) in Spain, dated June 29, 2022. The content explicitly details the results of the General Shareholders' Meeting regarding the appointment, reappointment, and resignation of members of the Board of Directors (Consejo de Administración), the Executive Commission (Comisión Ejecutiva), the Audit Committee (Comisión de Auditoría), and the Appointments and Remuneration/Sustainability Committee. This type of announcement, focusing on changes in board composition and governance structure following a shareholder meeting, aligns perfectly with the definition of Board/Management Information (MANG). While it stems from an AGM, the core subject is the resulting management structure changes, making MANG more specific than AGM-R, which usually covers the presentation materials themselves.
2022-06-29 Spanish
La Sociedad anuncia la convocatoria de la Junta General Ordinaria de Accionistas y remite propuestas de acuerdos.
AGM Information Classification · 99% confidence The document is an official communication addressed to the 'Comisión Nacional del Mercado de Valores' (CNMV, the Spanish securities market regulator) announcing a decision by the Board of Directors to convene an 'Junta General Ordinaria de Accionistas' (Annual General Shareholders' Meeting). The text explicitly details the date, location, and the full 'ORDEN DEL DÍA' (Agenda), which includes voting on annual accounts, re-election of auditors, appointment/re-election of directors, and modifications to bylaws. This content is the formal notice and agenda for a shareholder meeting, which aligns perfectly with the definition of materials shared for an Annual General Meeting (AGM). Although it mentions accompanying documents (like the announcement of the call and proposals), the core document itself is the official notice of the AGM, making 'AGM-R' the most appropriate classification, as it precedes the actual meeting.
2022-05-19 Spanish
La Comisión Ejecutiva de Pharma Mar, S.A. ha decidido la ejecución del Plan de Entrega Gratuita de Acciones aprobado por acuerdo de su Junta General Ordinaria de fecha 15 de abril de 2021.
Remuneration Information Classification · 99% confidence The document is a formal communication addressed to the 'Comisión Nacional del Mercado de Valores' (Spanish Securities Market Commission) dated April 28, 2022. It announces the execution of a 'Plan de entrega gratuita de acciones de la autocartera' (Free share delivery plan from treasury stock) approved by the Shareholders' General Meeting. This plan involves granting shares to employees and executives, detailing conditions like lock-up periods and resolution clauses based on employment status. This type of announcement, concerning the structure of capital or share distribution to employees/management, falls under Capital/Financing Update (CAP) or potentially Share Issue/Capital Change (SHA). Since the core action is the execution of a pre-approved plan to distribute treasury shares to employees as an incentive, it is fundamentally a capital structure/financing activity related to employee compensation, making 'CAP' (Capital/Financing Update) the most appropriate fit, as it details the mechanics of a capital-related incentive program. It is not a general earnings release (ER), a full annual report (10-K), or a simple dividend notice (DIV).
2022-04-28 Spanish

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.